Pancreatic enzyme elevation in chronic myeloid leukemia patients treated with nilotinib after imatinib failure.
about
European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemiaUpdate on the management of Philadelphia chromosome positive chronic myelogenous leukemia: role of nilotinibPractical management of patients with chronic myeloid leukemia.Efficacy and tolerability after unusually low doses of dasatinib in chronic myeloid leukemia patients intolerant to standard-dose dasatinib therapy.European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013.Optimizing outcomes in patients with chronic myeloid leukemia in chronic phase: comparative safety profiles of newer agents.Treatment of chronic myeloid leukemia when imatinib fails.Impact of comorbidities on the treatment of chronic myeloid leukemia with tyrosine-kinase inhibitors.Treatment recommendations for chronic myeloid leukemiaManagement of adverse events associated with tyrosine kinase inhibitors in chronic myeloid leukemia.Biliary and pancreatic complications of molecular targeted therapies in cancer imaging.Nilotinib: evaluation and analysis of its role in chronic myeloid leukemia.Nilotinib-associated acute pancreatitis.Long-term efficacy and safety of nilotinib therapy after imatinib failure in eosinophilic myeloproliferative neoplasm and ETV6-ABL rearrangement.
P2860
Q26749324-64EAE6F5-47B6-478F-8390-69303B071D3FQ26751285-E50C4861-6BF6-48B6-9394-134F9A2B4B95Q33849146-6C914C98-5203-401B-849D-176C1C695C9FQ34480473-A7F23200-3DA8-43AF-8622-6D45EC34C5CDQ37026032-ACEDC470-7F01-4F74-AFC6-4340CBA7AE87Q37763106-EEE1ECA2-54CC-4278-94D6-EE04F43A0162Q37827875-5AF29C83-9751-4575-8D5E-D54B3197A2DCQ38148243-13D64358-F38F-4374-A311-FD5BAB3783A9Q38181112-9A542839-6CB7-43E1-961C-4BA3DE1787CFQ38392679-E151BE88-F589-413F-9976-35F63BF7E9F0Q39119013-1D6023B3-C44A-45B2-8935-7A52A913FC2FQ39779762-B1D2F0E9-C211-4CF1-8C9D-E68792FDB19BQ54458606-65C2D7F5-1F2D-4C47-9AD1-53EAD45B4D8FQ55060713-FF87B66B-F6E8-4D7F-A6E2-101ABBFBB0DA
P2860
Pancreatic enzyme elevation in chronic myeloid leukemia patients treated with nilotinib after imatinib failure.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pancreatic enzyme elevation in ...... otinib after imatinib failure.
@en
Pancreatic enzyme elevation in ...... otinib after imatinib failure.
@nl
type
label
Pancreatic enzyme elevation in ...... otinib after imatinib failure.
@en
Pancreatic enzyme elevation in ...... otinib after imatinib failure.
@nl
prefLabel
Pancreatic enzyme elevation in ...... otinib after imatinib failure.
@en
Pancreatic enzyme elevation in ...... otinib after imatinib failure.
@nl
P2860
P50
P1433
P1476
Pancreatic enzyme elevation in ...... otinib after imatinib failure.
@en
P2093
Angela Poerio
Marilina Amabile
P2860
P304
P356
10.3324/HAEMATOL.2009.010496
P50
P577
2009-07-16T00:00:00Z